| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0888-7543(03)00117-4 |
| P698 | PubMed publication ID | 14559207 |
| P50 | author | Jörn Lötsch | Q43057635 |
| Carsten Skarke | Q56529015 | ||
| P2093 | author name string | Gerd Geisslinger | |
| P2860 | cites work | A sequencing method based on real-time pyrophosphate | Q28279786 |
| Real-time DNA sequencing using detection of pyrophosphate release | Q28297219 | ||
| An inventory of the human ABC proteins | Q33784414 | ||
| Choroid plexus epithelial expression of MDR1 P glycoprotein and multidrug resistance-associated protein contribute to the blood-cerebrospinal-fluid drug-permeability barrier | Q33856562 | ||
| Functional expression and localization of P-glycoprotein at the blood brain barrier | Q33960099 | ||
| Pharmacokinetic and pharmacodynamic implications of P-glycoprotein modulation | Q34303346 | ||
| A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants | Q34488592 | ||
| Drugs as P-glycoprotein substrates, inhibitors, and inducers | Q34627908 | ||
| MDR1 genotype-related pharmacokinetics and pharmacodynamics. | Q34990772 | ||
| Determination of single-nucleotide polymorphisms by real-time pyrophosphate DNA sequencing | Q35028450 | ||
| Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo | Q35113118 | ||
| Bayesian haplotype inference for multiple linked single-nucleotide polymorphisms | Q35793499 | ||
| MDR1 gene polymorphisms and disposition of the P-glycoprotein substrate fexofenadine | Q35803858 | ||
| Enzymatic method for continuous monitoring of inorganic pyrophosphate synthesis | Q38596289 | ||
| Frequency of C3435T polymorphism of MDR1 gene in African people | Q43705274 | ||
| Identification of functionally variant MDR1 alleles among European Americans and African Americans | Q43705904 | ||
| Response to antiretroviral treatment in HIV-1-infected individuals with allelic variants of the multidrug resistance transporter 1: a pharmacogenetics study | Q43865209 | ||
| Role of human MDR1 gene polymorphism in bioavailability and interaction of digoxin, a substrate of P-glycoprotein. | Q44110147 | ||
| Functional characterization of coding polymorphisms in the human MDR1 gene using a vaccinia virus expression system. | Q45732147 | ||
| MDR1 pharmacogenetics: frequency of the C3435T mutation in exon 26 is significantly influenced by ethnicity | Q46923500 | ||
| The pharmacological role of P-glycoprotein in the intestinal epithelium | Q47722866 | ||
| The LightCycler: a microvolume multisample fluorimeter with rapid temperature control. | Q50532955 | ||
| Frequency of single nucleotide polymorphisms in the P-glycoprotein drug transporter MDR1 gene in white subjects. | Q52965959 | ||
| The C3435T mutation in the human MDR1 gene is associated with altered efflux of the P-glycoprotein substrate rhodamine 123 from CD56+ natural killer cells | Q74127572 | ||
| Pharmacogenetics of the human drug-transporter gene MDR1: impact of polymorphisms on pharmacotherapy | Q74338359 | ||
| Distinct haplotype profiles and strong linkage disequilibrium at the MDR1 multidrug transporter gene locus in three ethnic Asian populations | Q74598011 | ||
| MDR1 genotype-related pharmacokinetics of digoxin after single oral administration in healthy Japanese subjects | Q77133730 | ||
| Effects of polymorphisms of MDR1, MRP1, and MRP2 genes on their mRNA expression levels in duodenal enterocytes of healthy Japanese subjects | Q78406835 | ||
| Modulation of steady-state kinetics of digoxin by haplotypes of the P-glycoprotein MDR1 gene | Q78500959 | ||
| P433 | issue | 5 | |
| P304 | page(s) | 503-510 | |
| P577 | publication date | 2003-11-01 | |
| P1433 | published in | Genomics | Q5533503 |
| P1476 | title | Simultaneous screening for three mutations in the ABCB1 gene | |
| P478 | volume | 82 |
Search more.